Zimmer Biomet Holdings, Inc. (ZBH)
100.85
-0.13
(-0.13%)
USD |
NYSE |
Aug 24, 16:00
100.85
0.00 (0.00%)
After-Hours: 20:00
Zimmer Biomet Holdings EPS Diluted (Quarterly) : 1.028 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.028 |
| March 31, 2026 | 1.216 |
| December 31, 2025 | 0.7032 |
| September 30, 2025 | 1.162 |
| June 30, 2025 | 0.7706 |
| March 31, 2025 | 0.9114 |
| December 31, 2024 | 1.198 |
| September 30, 2024 | 1.227 |
| June 30, 2024 | 1.176 |
| March 31, 2024 | 0.8361 |
| December 31, 2023 | 2.010 |
| September 30, 2023 | 0.7748 |
| June 30, 2023 | 0.9986 |
| March 31, 2023 | 1.105 |
| December 31, 2022 | -0.622 |
| September 30, 2022 | 0.9225 |
| June 30, 2022 | 0.7309 |
| March 31, 2022 | 0.0676 |
| December 31, 2021 | -0.4021 |
| September 30, 2021 | 0.6914 |
| June 30, 2021 | 0.6735 |
| March 31, 2021 | 0.9424 |
| December 31, 2020 | 1.594 |
| September 30, 2020 | 1.163 |
| June 30, 2020 | -0.999 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.462 |
| December 31, 2019 | 1.543 |
| September 30, 2019 | 2.083 |
| June 30, 2019 | 0.6484 |
| March 31, 2019 | 1.196 |
| December 31, 2018 | -4.417 |
| September 30, 2018 | 0.7897 |
| June 30, 2018 | 0.9042 |
| March 31, 2018 | 0.8539 |
| December 31, 2017 | 6.078 |
| September 30, 2017 | 0.48 |
| June 30, 2017 | 0.9043 |
| March 31, 2017 | 1.474 |
| December 31, 2016 | 0.33 |
| September 30, 2016 | 0.78 |
| June 30, 2016 | -0.16 |
| March 31, 2016 | 0.54 |
| December 31, 2015 | 0.62 |
| September 30, 2015 | 0.11 |
| June 30, 2015 | -0.91 |
| March 31, 2015 | 1.02 |
| December 31, 2014 | 0.91 |
| September 30, 2014 | 0.96 |
| June 30, 2014 | 1.03 |
| March 31, 2014 | 1.29 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 2.290 |
| Stryker Corp. | 3.306 |
| Globus Medical, Inc. | 1.103 |
| Solventum Corp. | 0.5309 |
| Boston Scientific Corp. | 0.615 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 199.60M |
| Revenue (Quarterly) | 2.177B |
| Total Expenses (Quarterly) | 1.979B |
| Enterprise Value | 26.32B |
| Gross Profit Margin (Quarterly) | 62.91% |
| Profit Margin (Quarterly) | 9.17% |
| Earnings Yield | 4.07% |
| Operating Earnings Yield | 7.01% |
| Normalized Earnings Yield | 4.810 |